These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 35322757)
1. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis. Cui J; Wang Y; Xue H Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757 [TBL] [Abstract][Full Text] [Related]
2. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. Chen T; Meng Y; Zhou Z; Li H; Wan L; Kang A; Guo W; Ren K; Song X; Chen Y; Zhao W Cell Death Differ; 2023 Jul; 30(7):1829-1848. PubMed ID: 37337032 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2. Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037 [TBL] [Abstract][Full Text] [Related]
4. LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD. Yang S; Zhang Y; Zhang Y; Yin L; Han X; Zhao X; Wang N; Xu L Int Immunopharmacol; 2024 Jan; 127():111444. PubMed ID: 38157698 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice. Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044 [TBL] [Abstract][Full Text] [Related]
6. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation Xu S; Wang Y; Li Z; Hua Q; Jiang M; Fan X Front Endocrinol (Lausanne); 2022; 13():889858. PubMed ID: 35957809 [TBL] [Abstract][Full Text] [Related]
8. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease. Liu J; Tang T; Wang GD; Liu B Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820 [No Abstract] [Full Text] [Related]
9. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis. Guo B; Cheng Y; Yao L; Zhang J; Lu J; Qi H; Chen H Cell Signal; 2022 Feb; 90():110190. PubMed ID: 34774989 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes. Wang XY; Lu LJ; Li YM; Xu CF Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA 29a alleviates mitochondrial stress in diet-induced NAFLD by inhibiting the MAVS pathway. Yang YL; Chuang YT; Huang YH Eur J Pharmacol; 2024 Nov; 982():176955. PubMed ID: 39209098 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. Xu M; Zheng XM; Jiang F; Qiu WQ J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055 [TBL] [Abstract][Full Text] [Related]
13. MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1. Ding J; Xia C; Cen P; Li S; Yu L; Zhu J; Jin J Mol Biol Rep; 2022 Aug; 49(8):7297-7305. PubMed ID: 35606603 [TBL] [Abstract][Full Text] [Related]
14. High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3. Wang X; Wang J Biol Chem; 2018 Mar; 399(4):397-406. PubMed ID: 29261513 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA GAS5 knockdown facilitates proliferation and impedes apoptosis by regulating miR-128-3p/FBLN2 axis in ox-LDL-induced THP-1 cells. Shen Z; Li H Clin Hemorheol Microcirc; 2021; 77(2):153-164. PubMed ID: 33074219 [TBL] [Abstract][Full Text] [Related]
16. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis. Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Lin HY; Wang FS; Yang YL; Huang YH Cells; 2019 Oct; 8(10):. PubMed ID: 31652636 [TBL] [Abstract][Full Text] [Related]
18. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway. Jin SS; Lin CJ; Lin XF; Zheng JZ; Guan HQ Ann Hepatol; 2022; 27(2):100584. PubMed ID: 34808393 [TBL] [Abstract][Full Text] [Related]
19. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade. Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323 [TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1. Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]